Tag archive for ‘Barr Pharmaceuticals’
Shiri Habib-Valdhorn On Monday, May 11th, 2015

Teva rejected opportunity to acquire Perrigo

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) had an opportunity to acquire US pharmaceuticals company Perrigo Company (NYSE:PRGO; TASE:PRGO) a few months ago, and said it was not interested, More...

Hillel Koren On Tuesday, April 21st, 2015

Teva bid for Mylan could come today – Bloomberg

Bloomberg reports that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) could publish a bid for its US rival Mylan Inc. (MYL) today, in what could turn out to be the largest deal of the year in More...

Teva Pharmaceutical Upgraded to ‘Outperform’ by Oppenheimer

Deutsche Bank set a $68.00 target price on Teva Pharmaceutical Industries (NASDAQ:TEVA) in a research note released on Monday morning. The firm currently has a a buy rating on the stock. Deutsche Bank has also More...

Wordpress site Developed by Fixing WordPress Problems